Plain-English translation of NCT06030011 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a digital tool called the Electronic Patient Visit Assessment (ePVA) that lets you report your cancer treatment symptoms—like difficulty swallowing, changes in taste or smell, and social challenges—directly to your medical team using your computer or phone. The researchers want to see if this real-time symptom tracking helps your doctors spot problems earlier and give you faster help during and after radiation therapy for head and neck cancer.
Many head and neck cancer patients struggle with side effects like swallowing problems and loss of taste during treatment, but doctors don't always catch these issues quickly enough to help. This study aims to find out whether tracking your symptoms digitally in real time helps doctors respond faster and improves your quality of life after treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll receive either the new digital symptom-tracking tool plus your usual cancer care, or usual care alone. If assigned to use the tool, you'll report your symptoms regularly through a digital system, which your doctors can see and respond to in real time. The study will follow you through your radiation therapy and for about 4 weeks after you finish treatment, tracking how well you're doing with swallowing, taste, smell, and social activities.
AI-generated summary from trial data · Jul 17, 2026 · Not medical advice
United States